{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:38:46Z","timestamp":1767983926857,"version":"3.49.0"},"reference-count":25,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1783,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1111\/j.1742-1241.2010.02422.x","type":"journal-article","created":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T14:50:12Z","timestamp":1287067812000},"page":"1681-1687","source":"Crossref","is-referenced-by-count":15,"title":["The impact of tramadol and dihydrocodeine treatment on quality of life of patients with cancer pain"],"prefix":"10.1155","volume":"64","author":[{"given":"W.","family":"Leppert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Majkowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,10,14]]},"reference":[{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB1|cit1","first-page":"877","article-title":"Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids","volume":"38","author":"Hennies","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0376-8716(91)90081-9","article-title":"Abuse potential and pharmacological comparison of tramadol and morphine","volume":"27","author":"Preston","year":"1991","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0304-3959(03)00212-4","article-title":"Impact of CYP2D6 genotype on postoperative tramadol analgesia","volume":"105","author":"Stamer","year":"2003","journal-title":"Pain"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1034\/j.1600-0773.2002.910203.x","article-title":"Affinities of dihydrocodeine and its metabolites to opioid receptors","volume":"91","author":"Schmidt","year":"2002","journal-title":"Pharmacol Toxicol"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2125.1998.00727.x","article-title":"The visceral and somatic antinociceptive effects of dihydrocodeine and its metabolite, dihydromorphine. A cross-over study with extensive and quinidine-induced poor matabolizers","volume":"45","author":"Wilder-Smith","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0304-3959(00)00414-0","article-title":"Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAID\u2019s: a randomized study comparing analgesia, antinociception and gastrointestinal effects","volume":"91","author":"Wilder-Smith","year":"2001","journal-title":"Pain"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB7|cit7","first-page":"528","article-title":"Kliniczna ocena dzialania DHC Continus u chorych z bolem przewlek\u0142ym","volume":"7","author":"Dobrogowski","year":"2003","journal-title":"Wspolcz Onkol"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB8|cit8","first-page":"246","article-title":"Ocena analgezji i objawow niepozadanych tramadolu i dihydrokodeiny o kontrolowanym uwalnianiu u chorych z bolem nowotworowym - na podstawie zmodyfikowanej skali ESAS","volume":"12","author":"Leppert","year":"2008","journal-title":"Wspolcz Onkol"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jpainsymman.2006.01.001","article-title":"Low morphine doses in opioid-naive cancer patients with pain","volume":"31","author":"Mercadante","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s00520-005-0807-6","article-title":"A validation study of the WHO analgesic ladder: a two-step vs three-step strategy","volume":"13","author":"Maltoni","year":"2005","journal-title":"Support Care Cancer"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpainsymman.2003.10.006","article-title":"Use of strong opioids in advanced cancer pain: a randomized trial","volume":"27","author":"Marinangeli","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB12|cit12","first-page":"105","article-title":"WHO analgesic ladder - or lift?","volume":"10","author":"Porta - Sales","year":"2003","journal-title":"Eur J Palliat Care"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB13|cit13","first-page":"1","article-title":"Ocena jakosci zycia u chorych z bolem nowotworowym leczonych tramadolem i morfina","volume":"6","author":"Leppert","year":"2002","journal-title":"Psychoonkologia"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0885-3924(99)00060-3","article-title":"High - dose tramadol in comparison to low - dose morphine for cancer pain","volume":"18","author":"Grond","year":"1999","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB15|cit15","first-page":"257","article-title":"Analgesic efficacy and side effects of oral tramadol and morphine administered orally in the treatment of cancer pain","volume":"51","author":"Leppert","year":"2001","journal-title":"Nowotwory J Oncol"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB16|cit16","first-page":"145","article-title":"Rola analgetykow opioidowych II stopnia drabiny analgetycznej Swiatowej Organizacji Zdrowia w leczeniu bolu nowotworowego","volume":"9","author":"Leppert","year":"2006","journal-title":"Onkol Pol"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/07420529509064501","article-title":"Analgesic effects of dihydrocodeine and tramadol when administered either in the morning or evening","volume":"12","author":"Hummel","year":"1995","journal-title":"Chronobiol International"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organisation for Research and Treatment of Cancer QLQ - C 30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Instit"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB19|cit19","first-page":"78","volume-title":"Jakosc Zycia w Chorobie Nowotworowej","author":"Majkowicz","year":"1994"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/FBP.0b013e3282eff109","article-title":"Antidepressant-like effect of tramadol in the unpredictable chronic mild stress procedure: possible involvement of the noradrenergic system","volume":"18","author":"Yalcin","year":"2007","journal-title":"Behav Pharmacol"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-3565(25)11227-5","article-title":"Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an \u201catypical\u201d opioid analgesic","volume":"260","author":"Raffa","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2005.11.054","article-title":"Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis","volume":"531","author":"Barann","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.1997.tb00035.x","article-title":"The analgesic tramadol has minimal effect on gastrointestinal motor function","volume":"43","author":"Wilder - Smith","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB24|cit24","first-page":"91","volume-title":"Clinical Oncology: A Functional Approach","author":"American Cancer Society","year":"1983"},{"key":"10.1111\/j.1742-1241.2010.02422.x-BIB25|cit25","first-page":"191","volume-title":"Evaluation of Chemotherapeutic Agents","author":"Karnofsky","year":"1949"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2010.02422.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2010.02422.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T19:13:02Z","timestamp":1740597182000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2010.02422.x"}},"subtitle":["Tramadol and dihydrocodeine impact on QL of cancer pain patients"],"short-title":[],"issued":{"date-parts":[[2010,10,14]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2010.02422.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10,14]]}}}